Abstract
Trigeminal neuralgia is a debilitating condition characterized by severe unilateral facial pain episodes that are most commonly attributed to vascular compression of the trigeminal nerve. Pain episodes usually occur in response to light touch and may last seconds to a few minutes. MRI is often the imaging of choice to evaluate the cause of trigeminal neuralgia and rule out other diagnoses. Medical management is reportedly successful in about 90% of cases and mainly includes antiepileptic medications such as carbamazepine or oxcarbazepine. However, in recalcitrant cases, microvascular decompressive surgery or palliative destructive surgery is often necessary.
References
Cruccu G, Truini A. Refractory trigeminal neuralgia. CNS Drugs. 2013;27(2):91–6. doi:10.1007/s40263-012-0023-0.
Guardiani E, Sadoughi B, Blitzer A, Sirois D. A new treatment paradigm for trigeminal neuralgia using botulinum toxin type a. Laryngoscope. 2014;124(2):413–7.
Zakrzewska JM, Linskey ME. Trigeminal neuralgia. BMJ Clin Evid. 2009:1–9.
Zhang J, Yang M, Zhou M, He L, Chen N, Zakrzewska JM. Non-antiepileptic drugs for trigeminal neuralgia. Cochrane Database Syst Rev. 2013; 12:CD004029.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Adamov, E., Fusco, H.N. (2017). Trigeminal Neuralgia. In: Kahn, S., Xu, R. (eds) Musculoskeletal Sports and Spine Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-50512-1_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-50512-1_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-50510-7
Online ISBN: 978-3-319-50512-1
eBook Packages: MedicineMedicine (R0)